2012
DOI: 10.1002/ajmg.a.35215
|View full text |Cite
|
Sign up to set email alerts
|

A de novo 14q12q13.3 interstitial deletion in a patient affected by a severe neurodevelopmental disorder of unknown origin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
4
0

Year Published

2013
2013
2020
2020

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 24 publications
(41 reference statements)
1
4
0
Order By: Relevance
“…We have found only two patients with a deletion similar to our case: patient 1, reported by Santen et al [2012], and patient 3, described by Dale et al [2012], while all other cases showed larger or smaller deletions [Shapira et al, 1994;Kamnasaran et al, 2001;Caliebe et al, 2011;Torgyekes et al, 2011;Fonseca et al, 2012;Piccione et al, 2012;Santen et al, 2012;Hayashi et al, 2015]. The two patients, respectively 7 and 1.5 years old, have hypothyroidism, movement disorders (chorea), hypo/oligodontia, and normal growth.…”
Section: Discussionsupporting
confidence: 75%
See 1 more Smart Citation
“…We have found only two patients with a deletion similar to our case: patient 1, reported by Santen et al [2012], and patient 3, described by Dale et al [2012], while all other cases showed larger or smaller deletions [Shapira et al, 1994;Kamnasaran et al, 2001;Caliebe et al, 2011;Torgyekes et al, 2011;Fonseca et al, 2012;Piccione et al, 2012;Santen et al, 2012;Hayashi et al, 2015]. The two patients, respectively 7 and 1.5 years old, have hypothyroidism, movement disorders (chorea), hypo/oligodontia, and normal growth.…”
Section: Discussionsupporting
confidence: 75%
“…Chromosome 14q11-q22 deletion syndrome (OMIM 613457) is a rare genomic disorder, caused by an interstitial deletion of the long arm of chromosome 14 with variable breakpoints. The deletion has been described as a contiguous gene syndrome in several reports [Shapira et al, 1994;Kamnasaran et al, 2001;Caliebe et al, 2011;Fonseca et al, 2012;Piccione et al, 2012;Santen et al, 2012]: FOXG1, NKX2-1, and PAX9 have been identified as the candidate dosage-sensitive key genes of clinical significance, while the role of other genes (i.e., GARNL1/TULIP1, NKX2-8, SLC25A21) is still debated.…”
Section: Introductionmentioning
confidence: 99%
“…Existing descriptions of 14q12q13.3 microdeletion are those reported by Fonseca et al 19) and Ponzi et al 1) , and we compar ed the clinical manifestations with these cases ( Table 1). Fonseca et al 19) reported various symptoms including growth and develop mental delays. In this case, EEG showed abnormal focal theta semirhythmic activity, and there were no abnormal findings on brain MRI 19) .…”
Section: Discussionmentioning
confidence: 87%
“…Fonseca et al 19) reported various symptoms including growth and develop mental delays. In this case, EEG showed abnormal focal theta semirhythmic activity, and there were no abnormal findings on brain MRI 19) . Further, the present case had a large deletion that resulted in a wide array of symptoms with severe developmental and growth delay compared to previous cases.…”
Section: Discussionmentioning
confidence: 99%
“…Most patients with this chromosomal abnormality share common clinical manifestations, such as microcephaly, micrognathia, broad nasal bridge, ear anomalies, hypotonia, developmental delay, congenital heart defects and agenesis of corpus callosum . So far, only 27 patients with proximal interstitial deletion of chromosome 14q11-q22 have been reported, including siblings and prenatally diagnosed cases [2][3][4][5][6][7][8][9][10][11][12][14][15][16][17][18][19][20][21][22].…”
Section: Introductionmentioning
confidence: 99%